Showing 38,081 - 38,100 results of 100,240 for search '(( 5 wt decrease ) OR ( 5 ((wt decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.75s Refine Results
  1. 38081

    Hyper-Hypo study: A Retrospective Observational Study of Neonatal Hypoglycemia Related to Maternal Hypertension by Thiruveni Ramkumar (17075051)

    Published 2023
    “…However, a sub-group comparison of neonates (with initial blood glucose <2.6 mmol/L) showed methyldopa to be marginally associated with a 2 mmol/L decrease from the mean initial blood glucose, mean 1.6 ± 0.5 mmol/L, and methyldopa (1.4 ± 0.5 mmol/L; p= .045). …”
  2. 38082

    Benefits of Therapeutic Drug Monitoring of Vancomycin: A Systematic Review and Meta-Analysis by Zhi-Kang Ye (474245)

    Published 2013
    “…Compared with non-TDM groups, TDM groups had significantly higher rates of clinical efficacy (OR = 2.62, 95%CI 1.34–5.11 P = 0.005) and decreased rates of nephrotoxicity (OR = 0.25, 95%CI 0.13–0.48 P<0.0001). …”
  3. 38083
  4. 38084
  5. 38085
  6. 38086
  7. 38087
  8. 38088
  9. 38089
  10. 38090
  11. 38091
  12. 38092
  13. 38093
  14. 38094
  15. 38095
  16. 38096

    Data_Sheet_1_Linkage analysis and residual heterozygotes derived near isogenic lines reveals a novel protein quantitative trait loci from a Glycine soja accession.docx by Yia Yang (13172682)

    Published 2022
    “…Single marker analysis and linkage analysis using 50 RHD-NILs validated the chromosome 14 protein QTL, and whole genome sequencing of RHD-NILs allowed us to reduce the QTL interval from ∼16.5 to ∼4.6 Mbp. We identified two genomic regions based on recombination events which had significant increases of 0.65 and 0.72% in seed protein content without a significant decrease in seed oil content. …”
  17. 38097
  18. 38098

    Transposon insertion mutants. by Marion Schoof (11999106)

    Published 2022
    “…(B) SDS-PAGE of culture supernatant from 16-h cultures of the strains indicated in A of the cluster LPSI: H5, H3, H7, H9, H18; LPSII: H13, H21, H22, H35 and QS H23, H45. …”
  19. 38099
  20. 38100

    Table_1_Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience.DOCX by Francisco Gascón-Giménez (12266840)

    Published 2023
    “…After a median follow-up of 14.2 months (IQR: 6.5–27.2), ARR decreased by 85.7% (p < 0.001) and GEL by 82.9%, from 0.41 to 0.07 (p < 0.001). …”